Kura Oncology, Inc.
KURA
$7.58
-$0.07-0.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.12M | -57.43M | -19.22M | -54.40M | -50.84M |
| Total Depreciation and Amortization | 224.00K | 241.00K | 204.00K | 208.00K | 202.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.57M | 5.31M | 5.89M | 5.02M | 5.01M |
| Change in Net Operating Assets | 32.55M | -20.05M | 282.26M | 5.74M | 3.10M |
| Cash from Operations | -28.78M | -71.93M | 269.13M | -43.44M | -42.53M |
| Capital Expenditure | -1.46M | -292.00K | -372.00K | 0.00 | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.40M | -101.12M | -94.58M | 45.54M | 43.18M |
| Cash from Investing | 58.94M | -101.41M | -94.96M | 45.54M | 43.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 515.00K | 143.00K | 806.00K | 2.20M | 3.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 515.00K | 143.00K | 806.00K | 2.20M | 3.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.68M | -173.19M | 174.98M | 4.30M | 3.68M |